Form 4: CalciMedica CBO Boosts Stake with Stock Purchases

CalciMedica's Chief Business Officer, Eric W. Roberts, increased his beneficial ownership through open market purchases and option exercises.

Summary

• Eric W. Roberts, CalciMedica's Chief Business Officer, Director, and 10% Owner, acquired additional shares of common stock.
• On August 19, 2025, Roberts purchased 1,000 shares of common stock at $2.79 per share.
• On August 20, 2025, he purchased an additional 2,000 shares of common stock at $2.72 per share.
• Also on August 20, 2025, Roberts exercised employee stock options to acquire 15,000 shares of common stock at an exercise price of $1.53 per share.
• Following these transactions, Roberts' total beneficial ownership of common stock is 1,036,986 shares (179,706 directly owned and 857,280 indirectly owned).
• Roberts also directly holds 57,750 employee stock options.

Sentiment

Score: 8

Explanation: The significant insider buying by a key executive and director suggests strong internal confidence in the company's prospects, which is a positive signal for investors.

Positives

• A high-ranking insider (Chief Business Officer, Director, and 10% Owner) is increasing their stake in the company, signaling confidence in future prospects.
• The exercise of options at $1.53 and subsequent open market purchases at $2.79 and $2.72 indicate a belief that the stock is undervalued or has significant upside potential.
• The total beneficial ownership of 1,036,986 common shares and 57,750 employee stock options demonstrates significant alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the insider buying as a positive indicator of management's belief in the company's value and future growth, potentially increasing investor confidence.

Key Dates

Recommendation

The Chief Business Officer, Director, and 10% owner of CalciMedica, Eric W. Roberts, significantly increased his stake in the company through open market purchases and option exercises. This strong insider buying signals high confidence in the company's future prospects and valuation, making it a compelling 'buy' signal for investors.

Keywords

CalciMedica, CALC, Insider Trading, Form 4, Stock Purchase, Option Exercise, Eric W. Roberts, Biotechnology, Pharmaceuticals, Executive Compensation